Lidar maker Luminar Technologies, stung by a recent Wall Street downgrade, is responding in an unusual way: taking its case directly to the shareholders.
In a letter seen by CNBC on Friday morning, Luminar CFO Tom Fennimore – himself a former Goldman Sachs managing director – takes issue with arguments made in a bearish note by Goldman analyst Mark Delaney earlier this week.
related investing news
Delaney on Tuesday afternoon cut Goldman’s rating on Luminar to sell, from hold, arguing that its shares are overpriced relative to key competitors and that Luminar’s own pricing assumptions are unrealistically high.
Luminar’s shares have fallen about 16% since Delaney’s note was published.
“We continue to see Luminar as one of a handful of leaders in the very competitive lidar industry,” Delaney wrote. “However, we see downside to the company’s margin outlook with the company targeting revenue per vehicle of ~$1k which we believe implies ASPs [average selling prices] roughly 50-100% higher than key competitors.”
Simply put, while Delaney acknowledges that Luminar is one of only a few lidar makers winning deals with major automakers, he thinks that Luminar won’t be able to get the prices it’s hoping to get from those automakers. And based on 2025 revenue assumptions, he sees Luminar trading at four times the valuation of competitors Innoviz and Hesai, both of which have also won business from automakers.
Fennimore argues that Delaney missed two key points.
“One, our tech is better, and people typically pay a premium for tech, but to us this isn’t a theoretical exercise: This is pricing that we actually have in place,” Fennimore told CNBC in an interview on Friday morning.
Fennimore’s letter points out that Luminar has already signed contracts to provide hardware and software for over 20 upcoming new vehicles from major automakers including Volvo, Polestar, Mercedes-Benz and Chinese auto giant SAIC Motor. Those contracts lock in pricing through the life of those upcoming models, he said.
“‘Premium pricing’ isn’t a theoretical concept we are forecasting, but an achievement we have already made in our major customer contracts,” Fennimore wrote in the shareholder letter.
And the second point Fennimore says Goldman missed: The time frame Delaney chose to compare Luminar’s valuation against those of its rivals.
“We believe using 2025 revenue as a valuation benchmark versus peers dramatically undervalues Luminar, as many of the 20+ vehicle lines we have been awarded are not expected to reach production until beyond 2025,” he wrote.
Put another way, some of the big contracts that Luminar has already signed won’t generate significant revenue until those vehicles launch in the second half of the decade, Fennimore said.
The decision to take the rebuttal directly to Luminar’s shareholders is unusual, but Fennimore believes it’s warranted – and he hinted that Luminar might choose to send more letters like this in the future.
“Whenever anybody raises valid and thoughtful concerns about us, we want to respond with valid and thoughtful facts,” Fennimore told CNBC. “Because I think the capital markets rely on having a good and factual debate.”
ivermectin pills canada – cost carbamazepine order tegretol 400mg sale
accutane 40mg pill – buy dexona pill linezolid drug
purchase amoxil online – buy amoxil online combivent order online
azithromycin brand – cost azithromycin 250mg nebivolol pills
brand prednisolone – azithromycin 250mg tablet brand prometrium 200mg
buy cheap generic gabapentin – itraconazole where to buy order sporanox 100 mg generic
lasix over the counter – piracetam generic buy generic betamethasone
acticlate order online – glucotrol 10mg price glucotrol buy online
buy clavulanate generic – buy augmentin 625mg generic duloxetine 40mg cheap
rybelsus 14 mg uk – buy periactin 4 mg sale cyproheptadine 4 mg brand
buy tizanidine – buy hydroxychloroquine generic hydrochlorothiazide 25mg generic
buy atorvastatin 40mg for sale – atorvastatin 10mg pill order zestril 10mg generic
buy generic atorvastatin 40mg – buy generic lisinopril lisinopril cheap
buy prilosec 20mg online cheap – tenormin 100mg for sale oral tenormin 100mg
medrol where to buy – buy pregabalin 75mg pill cost triamcinolone
cytotec 200mcg price – buy cytotec tablets diltiazem tablet
buy acyclovir pill – crestor online order buy crestor 20mg online
buy domperidone 10mg generic – flexeril online cyclobenzaprine 15mg tablet